Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
InChi: InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H
2017 Dec 29
that is currently under evaluation in human clinical trials for the treatment of acute severe pain
InChi: InChI=1S/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4
SC144 hydrochloride yrrhizic acid InChi: InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10HSC144 hydrochloride is a first in class, orally active gp130 (IL6 beta) inhibitor. SC144 hydrochloride binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, abrogates Stat3 phosphorylation and nuclear translocation, and further inhibits the expression of downstream target genes. SC144 hydrochloride shows potent inhibition of gp130 ligand triggered signaling. SC144 hydrochloride induces apoptosis in human ovarian cancer cells. Product